Therapeutic efficacy of PCSK9 monoclonal antibodies in statin-nonresponsive patients with hypercholesterolemia and dyslipidemia: A systematic review and meta-analysis.
about
Therapeutic efficacy and safety of PCSK9-monoclonal antibodies on familial hypercholesterolemia and statin-intolerant patients: A meta-analysis of 15 randomized controlled trials.Proprotein convertase inhibition: Paralyzing the cell's master switches.Investigational therapies for hypercholesterolemia.Correlation between Traditional Chinese Medicine Constitution and Dyslipidemia: A Systematic Review and Meta-Analysis.Systematic Review and Network Meta-Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia.
P2860
Therapeutic efficacy of PCSK9 monoclonal antibodies in statin-nonresponsive patients with hypercholesterolemia and dyslipidemia: A systematic review and meta-analysis.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Therapeutic efficacy of PCSK9 ...... atic review and meta-analysis.
@ast
Therapeutic efficacy of PCSK9 ...... atic review and meta-analysis.
@en
Therapeutic efficacy of PCSK9 ...... atic review and meta-analysis.
@nl
type
label
Therapeutic efficacy of PCSK9 ...... atic review and meta-analysis.
@ast
Therapeutic efficacy of PCSK9 ...... atic review and meta-analysis.
@en
Therapeutic efficacy of PCSK9 ...... atic review and meta-analysis.
@nl
prefLabel
Therapeutic efficacy of PCSK9 ...... atic review and meta-analysis.
@ast
Therapeutic efficacy of PCSK9 ...... atic review and meta-analysis.
@en
Therapeutic efficacy of PCSK9 ...... atic review and meta-analysis.
@nl
P2093
P921
P1476
Therapeutic efficacy of PCSK9 ...... atic review and meta-analysis.
@en
P2093
Qiu Chongrong
Zhang Qian
Zhong Jian
P304
P356
10.1016/J.IJCARD.2016.07.239
P577
2016-07-30T00:00:00Z